Page 48 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chinese state firm Sinopharm aims to produce 1 billion vaccine doses in 2021 2 minutes read By Javier Garcia Beijing, Feb 26 (efe-epa).- The head of China’s state-owned pharmaceutical company Sinopharm, Liu Jingzhen, announced Friday that they plan to produce one billion doses of its inactivated coronavirus vaccine this year, a large part of it for export. During a visit organized for the media to the Sinopharm facilities near Beijing, Liu revealed that the pharmaceutical company was improving its production capabilities to produce more vaccines. Annual production of Sinopharm would account for half of the two nillion doses that China plans to produce this year, according to the National Vaccine Industry Association head Feng Duojia, who recently said that the country would double that amount by 2022.

United statesSouth africaUnited arab emiratesDominican republicWang huiSouth africanLiu jingzhenJavier garciaFeng duojiaMartin vizcarraCansino biologicsNational vaccine industry associationInstitute of biological productsNational medical products administrationAcademy of military medical sciencesInstitute of biological product